ETHERLive delivers real-time price and volume data across 16+ exchanges to users in a clear and easy-to-understand package. Users can get up-to-the-second updates for each exchange/currency pair, as well as aggregated market averages for each exchange, currency, and the market as a whole. It also provides a global converted average of all the currency pairs monitored by ETHNews, converted to USD.


24hr ---

The Basics

Learn the basics of Ethereum and various cryptocurrency technologies

Learn More

What is Ethereum?

Understand the underlying principles of the Ethereum Platform

Learn More

The Blockchain

Discover the revolutionizing technology known as the blockchain

Learn More

Press Release

Submit a press release for consideration on ETHNews

Submit Press

Story / Dapp

Submit a story or DAPP to be considered for publication on ETHNews.

Submit Story


Submit "Ethereum Explainer" content for consideration to be featured on ETHNews

Submit Topic
ETHNews Logo
Ether Price Analysis
Contact Us

Pistoia Alliance Encourages Collaboration By Big Pharma On Blockchain Initiatives



De Silva

The Pistoia Alliance recently revealed the results of its webinar survey of senior pharmaceutical and life science leaders. While 22 percent of life science companies have implemented or experimented with blockchain technology, 83 percent of survey respondents anticipate blockchain adoption within the next five years.

The Pistoia Alliance is a not-for-profit association of life science companies, vendors, publishers, and academic groups. Its mission is to lower barriers to innovation in life sciences research and development.

On Monday, June 26, the Pistoia Alliance released survey results which demonstrated enthusiasm for blockchain in the pharmaceutical industry. A significant majority of respondents (83 percent) expect blockchain adoption within the next five years.

As such, the Pistoia Alliance is promoting cooperation between stakeholders, especially during the early phases of adoption. The alliance advises that industry-wide data sharing standards will enhance security and inspire patients to share their data with companies. These advances could benefit researchers and patients today and down the road.

45 percent of survey respondents pegged regulatory issues as the biggest hurdle to widespread adoption of blockchain technology. Potential concerns about data privacy (26 percent) were a distant second.

In terms of use cases, 68 percent of survey respondents believe that blockchain will have the greatest impact by “ensuring an auditable trail to safeguard drug provenance,” or tracing the origin of a drug. 60 percent of respondents also noted the opportunity for storing medical records using blockchain technology.

In an email to ETHNews, Nick Lynch, a consultant for The Pistoia Alliance, explained that blockchain has piqued the interest of the pharmaceutical industry “due to its ability to provide a secure, scalable, disintermediated system for data storage.”

Lynch also explained that blockchain will shift power “from practitioner to patient” since patients will control their data and how it is used. “In the future, patients could even monetize access to their personal data, giving individual companies access to ‘blocks’ of their data for research purposes.”

“This shift is changing the entire model of healthcare from early R&D all the way to frontline delivery. The pharmaceutical industry must collaboratively explore solutions that enable patients to control their personal data, while ensuring they retain access to data for their own R&D projects.”

Matthew De Silva

Matthew has a passion for law and technology. He graduated from Georgetown University, where he studied international economics and music. Matthew enjoys biking and listening to tech podcasts. He lives in Los Angeles.

ETHNews is committed to its Editorial Policy

Like what you read? Follow us on Twitter @ETHNews_ to receive the latest Pistoia Alliance, Big Pharma or other Ethereum healthcare news.